ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$149.8
*  
0.75
 negative 
0.5%
Get ALXN Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Exact Sciences (EXAS) Jumps: Stock Adds 10.2% in Session - Tale of the Tape
4/1/2014 8:51:01 AM - Zacks.com

Glaxo Presents Darapladib Data - Analyst Blog
3/31/2014 6:30:01 PM - Zacks.com

Idera Soars on Phase II Drug Data - Analyst Blog
3/31/2014 5:06:01 PM - Zacks.com

MannKind Down on FDA's Briefing Document - Analyst Blog
3/31/2014 4:45:01 PM - Zacks.com

FDA Nod for Biogen's Alprolix - Analyst Blog
3/31/2014 4:00:01 PM - Zacks.com

EC Approves Roche/Halozyme's MabThera SC - Analyst Blog
3/31/2014 11:30:01 AM - Zacks.com

Integra LifeSciences Introduces Wound Matrix - Analyst Blog
3/28/2014 2:34:01 PM - Zacks.com

CVS Caremark Receives FEP contract - Analyst Blog
3/28/2014 2:10:01 PM - Zacks.com

Gilead's HCV Candidate Under Review in the EU - Analyst Blog
3/28/2014 11:40:01 AM - Zacks.com

BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog
3/28/2014 11:30:01 AM - Zacks.com

Stocks Move Higher in Early Trading Despite Drop in Consumer Sentiment
3/28/2014 10:31:00 AM - Knobias

Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape
3/28/2014 9:46:01 AM - Zacks.com

Insmed Incorporated saw its shares rise more than 7% in the session. - Tale of the Tape
3/28/2014 9:04:01 AM - Zacks.com

MEI Pharma, Inc. (MEIP) in Focus: Stock up 12.1% - Tale of the Tape
3/28/2014 8:44:01 AM - Zacks.com

Exelixis' Cometriq Approved in the EU - Analyst Blog
3/27/2014 6:00:01 PM - Zacks.com

Insmed Down on Disappointing Arikayce Results - Analyst Blog
3/27/2014 5:48:01 PM - Zacks.com

Nektar Rises on FDA Notification (revised) - Analyst Blog
3/27/2014 2:50:01 PM - Zacks.com

Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
3/27/2014 11:00:01 AM - Zacks.com

China Cord Blood Corporation (CO) Soars: Stock Up 5.7% - Tale of the Tape
3/27/2014 9:39:01 AM - Zacks.com

Retrophin (RTRX) Catches Eye: Stock Moves 7.9% Higher - Tale of the Tape
3/26/2014 9:54:01 AM - Zacks.com

What Falling Estimates & Price Mean for Kythera (KYTH) - Tale of the Tape
3/26/2014 8:57:01 AM - Zacks.com

Time to Focus on Alexion (ALXN) for Strong Earnings Growth Potential - Tale of the Tape
3/26/2014 8:51:01 AM - Zacks.com

Galectin Therapeutics, Inc. (GALT) in Focus: Stock Moves Up 8.84% - Tale of the Tape
3/26/2014 8:44:01 AM - Zacks.com

Large-Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
3/26/2014 8:12:00 AM - Seeking Alpha

AstraZeneca's Forxiga Approved in Japan - Analyst Blog
3/25/2014 4:45:01 PM - Zacks.com